Muhammad Anjum, MD
General Practice · Shreveport, LANPI 1275744526
Payments from drug & device makers
What this record shows
This record is dominated by grants: $25,000 of the $33,053 with a category attached, or 75.6%. Medtronic accounts for 82.6% of it on its own, with 27 other manufacturers making up the rest. Reporting peaked in 2019 at $29,231 and has fallen 99.7% since, to $92 in 2024. Among general practice clinicians in LA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 116 payments — averaging $284.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$27K
- Kyowa Kirin, Inc.$2K
- Lundbeck LLC$745
- Abbott$591
- AbbVie$302
- Acadia Pharmaceuticals Inc$251
- plus $2K from 22 others
What the payments were for
- Consulting fees$2,8959%
- Speaking & faculty fees$6722%
- Grants$25,00076%
- Travel & lodging$1,4554%
- Food & beverage$2,9619%
- Education$700%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 27 | $27,295 |
| Kyowa Kirin, Inc. | 2 | $2,231 |
| Lundbeck LLC | 7 | $745 |
| Abbott | 7 | $591 |
| AbbVie(2 entities) | 9 | $302 |
| Acadia Pharmaceuticals Inc | 2 | $251 |
| Boston Scientific | 2 | $233 |
| Amneal Pharmaceuticals LLC | 8 | $151 |
| UCB, Inc. | 3 | $150 |
| Teva Pharmaceuticals USA, Inc. | 1 | $131 |
| Acorda Therapeutics, Inc | 2 | $124 |
| MDD US Operations, LLC | 5 | $90 |
| Ipsen Biopharmaceuticals, Inc | 4 | $87 |
| Adamas Pharmaceuticals, Inc. | 5 | $84 |
| Pfizer | 5 | $81 |
| AstraZeneca | 5 | $75 |
| Sunovion Pharmaceuticals Inc. | 2 | $71 |
| Amgen(2 entities) | 3 | $66 |
| Eisai Inc. | 2 | $44 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $43 |
| Argenx US, Inc. | 2 | $37 |
| Biogen | 2 | $36 |
| Jazz Pharmaceuticals Inc. | 2 | $33 |
| EMD Serono, Inc. | 2 | $32 |
| TG Therapeutics, Inc. | 1 | $26 |
| Arbor Pharmaceuticals, Inc. | 1 | $18 |
| Avanir Pharmaceuticals, Inc. | 1 | $13 |
| Livanova USA, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$33,053 in reported general payments places this provider in the 95th percentile of 1,221 general practice providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ZeposiaOzanimod Hydrochloride | 21 | $92,598 |
| Levetiracetam | 18 | $223 |
Paid to pharmacies, not to this prescriber.
Other general practice in Shreveport
- Michael WoolbertShreveport$5K
- Caroline HaynieShreveport$4K
- James LowderShreveport$4K
- Morgan VanzandtShreveport$3K
- William CaldwellMetairie$943K
- William MaloneLafayette$46K
- Melissa RatliffBarksdale Afb$22K
- Louis PassauerMandeville$20K
- Stan Cowley JrMetairie$15K
- Justin TarverMonroe$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.